These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 34293985)
1. Acute hepatitis C virus infection and direct-acting antiviral drugs: Perfect combination to eliminate the epidemic? Gómez-Ayerbe C; Palacios R; Ríos MJ; Téllez F; Sayago C; Martín-Aspas A; Camacho A; Muñoz L; Santos J; Int J STD AIDS; 2021 Nov; 32(13):1257-1260. PubMed ID: 34293985 [TBL] [Abstract][Full Text] [Related]
2. Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study). Monin MB; Ingiliz P; Lutz T; Scholten S; Cordes C; Martínez-Rebollar M; Spinner CD; Nelson M; Rausch M; Bhagani S; Peters L; Reiberger T; Mauss S; Rockstroh JK; Boesecke C; Clin Infect Dis; 2023 Feb; 76(3):e607-e612. PubMed ID: 36004410 [TBL] [Abstract][Full Text] [Related]
3. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan. Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032 [TBL] [Abstract][Full Text] [Related]
4. The 'Viennese epidemic' of acute HCV in the era of direct-acting antivirals. Chromy D; Bauer DJM; Simbrunner B; Jachs M; Hartl L; Schwabl P; Schwarz C; Rieger A; Grabmeier-Pfistershammer K; Trauner M; Ferenci P; Mandorfer M; Gschwantler M; Reiberger T J Viral Hepat; 2022 May; 29(5):385-394. PubMed ID: 35274399 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis and Clinical Manifestations of Acute Hepatitis C Infection in People Living with HIV. O'Shea J; Oliver N; Cartwright EJ AIDS Patient Care STDS; 2022 May; 36(5):172-177. PubMed ID: 35507325 [TBL] [Abstract][Full Text] [Related]
6. Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012-2018. Cotte L; Hocqueloux L; Lefebvre M; Pradat P; Bani-Sadr F; Huleux T; Poizot-Martin I; Pugliese P; Rey D; Cabié A; Clin Infect Dis; 2021 Nov; 73(9):e3266-e3274. PubMed ID: 33400777 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C reinfection with protease inhibitor-resistant hepatitis C virus in an HIV-coinfected MSM. Yilmaz GR; Boesecke C; Schwarze-Zander C; Rockstroh JK Liver Int; 2020 Jan; 40(1):47-50. PubMed ID: 31612570 [TBL] [Abstract][Full Text] [Related]
8. Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study. Isfordink CJ; Boyd A; Sacks-Davis R; van Santen DK; Smit C; Martinello M; Stoove M; Berenguer J; Wittkop L; Klein MB; Rauch A; Salmon D; Lacombe K; Stewart A; Schinkel J; Doyle JS; Hellard M; van der Valk M; Matthews GV; Lancet Public Health; 2023 Apr; 8(4):e294-e304. PubMed ID: 36965984 [TBL] [Abstract][Full Text] [Related]
9. High efficacy of interferon-free therapy for acute hepatitis C in HIV-positive patients. Chromy D; Mandorfer M; Bucsics T; Schwabl P; Scheiner B; Schmidbauer C; Aichelburg MC; Ferenci P; Trauner M; Peck-Radosavljevic M; Reiberger T United European Gastroenterol J; 2019 May; 7(4):507-516. PubMed ID: 31065368 [TBL] [Abstract][Full Text] [Related]
10. Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individuals. Berenguer J; Gil-Martin Á; Jarrin I; Montes ML; Domínguez L; Aldámiz-Echevarría T; Téllez MJ; Santos I; Troya J; Losa JE; Serrano R; De Guzmán MT; Calvo MJ; González-García JJ; AIDS; 2019 Mar; 33(4):685-689. PubMed ID: 30829744 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis C virus infection among men who have sex with men with human immunodeficiency virus-1 infection between 2010 and 2020 in Japan: A single-center retrospective cohort study. Nishikawa K; Kimura M; Imamura J; Kimura K J Infect Chemother; 2023 Mar; 29(3):263-268. PubMed ID: 36585274 [TBL] [Abstract][Full Text] [Related]
12. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies. Sacks-Davis R; van Santen DK; Boyd A; Young J; Stewart A; Doyle JS; Rauch A; Mugglin C; Klein M; van der Valk M; Smit C; Jarrin I; Berenguer J; Lacombe K; Requena MB; Wittkop L; Leleux O; Bonnet F; Salmon D; Matthews GV; Guy R; Martin NK; Spelman T; Prins M; Stoove M; Hellard M; Lancet HIV; 2024 Feb; 11(2):e106-e116. PubMed ID: 38224708 [TBL] [Abstract][Full Text] [Related]
13. All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019. Requena MB; Protopopescu C; Stewart AC; van Santen DK; Klein MB; Jarrin I; Berenguer J; Wittkop L; Salmon D; Rauch A; Prins M; van der Valk M; Sacks-Davis R; Hellard ME; Carrieri P; Lacombe K; Int J Drug Policy; 2024 Feb; 124():104311. PubMed ID: 38184902 [TBL] [Abstract][Full Text] [Related]
14. Decline in Hepatitis C Virus (HCV) Incidence in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Progress to HCV Microelimination in the United Kingdom? Garvey LJ; Cooke GS; Smith C; Stingone C; Ghosh I; Dakshina S; Jain L; Waters LJ; Mahungu T; Ferro F; Sood C; Freeman C; Phillips C; Dhairyawan R; Burholt R; Sharp H; Ullah S; Gilleece Y; Brown A; Orkin C; Rodger A; Bhagani S Clin Infect Dis; 2021 Jan; 72(2):233-238. PubMed ID: 32211763 [TBL] [Abstract][Full Text] [Related]
15. A Treatment-as-Prevention Trial to Eliminate Hepatitis C Among Men Who Have Sex With Men Living With Human Immunodeficiency Virus (HIV) in the Swiss HIV Cohort Study. Braun DL; Hampel B; Ledergerber B; Grube C; Nguyen H; Künzler-Heule P; Shah C; Salazar-Vizcaya L; Conen A; Flepp M; Stöckle M; Béguelin C; Schmid P; Rougemont M; Delaloye J; Bernasconi E; Nicca D; Böni J; Rauch A; Kouyos RD; Günthard HF; Fehr JS Clin Infect Dis; 2021 Oct; 73(7):e2194-e2202. PubMed ID: 32761122 [TBL] [Abstract][Full Text] [Related]
16. Perceptions of hepatitis C treatment and reinfection risk among HIV-positive men who have sex with men and engage in high risk behaviours for hepatitis C transmission: The CEASE qualitative study. Marshall AD; Martinello M; Treloar C; Matthews GV Int J Drug Policy; 2022 Nov; 109():103828. PubMed ID: 35994937 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of an HCV elimination program targeting the Viennese MSM population. Jachs M; Binter T; Chromy D; Schalk H; Pichler K; Bauer D; Simbrunner B; Hartl L; Schmidbauer C; Mayer F; Strassl R; Mandorfer M; Gschwantler M; Reiberger T Wien Klin Wochenschr; 2021 Jul; 133(13-14):635-640. PubMed ID: 34181068 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system. Lam JO; Hurley LB; Chamberland S; Champsi JH; Gittleman LC; Korn DG; Lai JB; Quesenberry CP; Ready J; Saxena V; Seo SI; Witt DJ; Silverberg MJ; Marcus JL Int J STD AIDS; 2019 Jun; 30(7):689-695. PubMed ID: 31046611 [TBL] [Abstract][Full Text] [Related]